View the CIPRULZ DRY SUSPENSION 250 MG/5ML registration information details.
Back to drug list
ItemsDrug Registration information
ID1332
No1332
Brand NameCIPRULZ DRY SUSPENSION 250 MG/5ML
IngredientsCIPROFLOXACIN AS (HCL) 250 MG/5ML
Dosage FormPOWDER FOR SUSPENSION
Primary PackagingBOTTLE
Storage
Shelf Life2 YEARS
Pack Size60 ML/BOTTLE/BOX
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsLOWER RESPIRATORY TRACT INFECTION DUE TO GRAM-NEGATIVE BACTERIA, CHRONIC SUPPURATIVE OTITIS MEDIA, URINARY TRACT INFECTION, GENITAL TRACT INFECTION, INTRA-ABDOMINAL INFECTION, INFECTION OF THE SKIN AND SOFT TISSUE, INFECTION OF BONE AND JOINTS, INFECTION OF THE GASTRO-INTESTINAL.
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionOFF WHITE GRANULAR POWDER, OFF WHITE COLORED VISCOUS SUSPENSION HAVING BANANA FLAVOR, VISUALLY FREE FROM FOREIGN PARTICLES AFTER RECONSTITUTION.
Note
License OwnerKONGCHAI-LAO PHARMA SOLE CO.,LTD
ManufacturerFOCUS & RULZ PHARMACEUTICALS (PVT) LTD
CountryPAKISTAN
Import Registration No
Import Registration Date
ActivitySTEP 1: RECEIVE (RENEW)
Applied Date29/05/2025
FDD Registration No06 I 4740/19
FDD Registration Date26/09/2022
Expiry Date25/09/2025
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA